ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
Dow Jones
42.392,27
-0,36%
Euro vs US Dollar
1,02699
0,02%
Bitcoin
97.124,07
0,23%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Revive Therapeutics Ltd (RVV) Börsenkurse

Revive Therapeutics Ltd

Revive Therapeutics Ltd (RVV)

Revive Therapeutics Ltd
0,08
0,00
(0,00%)
Geschlossen 03 Januar 10:00PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,08
Gebot
0,075
Fragen
0,085
Volumen
-
0,00 Tagesbereich 0,00
0,08 52-Wochen-Bereich 0,08
Marktkapitalisierung
33,485M
Handelsende
0,08
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
418.564.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,97
Gewinn pro Aktie (EPS)
-0,01
Erlöse
-
Nettogewinn
-5,62M

Über Revive Therapeutics Ltd

Sektor
Pharmaceutical Preparations
Branche
Unit Inv Tr, Closed-end Mgmt
Website
www.revivethera.com
Hauptsitz
Toronto, Ontario, Can
Gegründet
2014
Revive Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker RVV. The last closing price for Revive Therapeutics was $0,08. Over the last year, Revive Therapeutics shares have traded in a share price range of $ 0,08 to $ 0,08.

Revive Therapeutics currently has 418.564.000 shares in issue. The market capitalisation of Revive Therapeutics is $33,49 million. Revive Therapeutics has a price to earnings ratio (PE ratio) of -5.97.

RVV Neueste Nachrichten

Weitere Nachrichten

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

29 März 2022
InvestorsHub NewsWire

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

                              HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...

24 Februar 2022
InvestorsHub NewsWire

Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

 Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation  TORONTO, February 15, 2022 -- Revive...

16 Februar 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 701 subjects dosed to date Initiating enrollment activities in Turkey as part of its...

19 Januar 2022
InvestorsHub NewsWire

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

07 Januar 2022
InvestorsHub NewsWire

Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant

 Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant TORONTO, November 16, 2021 -- InvestorsHub NewsWire -- Revive...

16 November 2021
InvestorsHub NewsWire

Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF

TORONTO, Sept. 21, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life...

22 September 2021
InvestorsHub NewsWire

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trialfor Bucillamine in COVID-19

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19   Phase 3 clinical trial ongoing with next DSMB meeting at 600 completed...

15 Juli 2021
InvestorsHub NewsWire

Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics

  Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics   TORONTO, June 17, 2021 -- InvestorsHub NewsWire...

17 Juni 2021
InvestorsHub NewsWire

Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India

Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India   TORONTO, June 8, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd...

08 Juni 2021
InvestorsHub NewsWire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.080.080.0800CS
4000.080.080.0800CS
12000.080.080.0800CS
26000.080.080.0800CS
52000.080.080.0800CS
156000.080.080.0800CS
260000.080.080.0800CS

RVV - Frequently Asked Questions (FAQ)

What is the current Revive Therapeutics share price?
The current share price of Revive Therapeutics is $ 0,08
How many Revive Therapeutics shares are in issue?
Revive Therapeutics has 418.564.000 shares in issue
What is the market cap of Revive Therapeutics?
The market capitalisation of Revive Therapeutics is CAD 33,49M
What is the 1 year trading range for Revive Therapeutics share price?
Revive Therapeutics has traded in the range of $ 0,08 to $ 0,08 during the past year
What is the PE ratio of Revive Therapeutics?
The price to earnings ratio of Revive Therapeutics is -5,97
What is the reporting currency for Revive Therapeutics?
Revive Therapeutics reports financial results in CAD
What is the latest annual profit for Revive Therapeutics?
The latest annual profit of Revive Therapeutics is CAD -5,62M
What is the registered address of Revive Therapeutics?
The registered address for Revive Therapeutics is 82 RICHMOND STREET EAST, SUITE 105, TORONTO, ONTARIO, M5C 1P1
What is the Revive Therapeutics website address?
The website address for Revive Therapeutics is www.revivethera.com
Which industry sector does Revive Therapeutics operate in?
Revive Therapeutics operates in the UNIT INV TR, CLOSED-END MGMT sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WEDWestaim Corporation
$ 31,15
(502,51%)
3,22k
ELBMElectra Battery Materials Corporation
$ 2,89
(344,62%)
37,59k
MTKMontauk Metals Inc
$ 0,01
(100,00%)
1.000
IBOUniversal Ibogaine Inc
$ 0,01
(100,00%)
1.000
VMY.HVoice Mobility International Inc
$ 0,01
(100,00%)
1.000
CPLCopper Lake Resources Ltd
$ 0,005
(-50,00%)
113k
RHCRoyal Helium Ltd
$ 0,02
(-33,33%)
1,46M
ULTUltra Lithium Inc
$ 0,01
(-33,33%)
29,43k
LBILions Bay Capital Inc
$ 0,02
(-33,33%)
2,5k
RECRecord Resources Inc
$ 0,025
(-28,57%)
73k
QUISQuisitive Technology Solutions Inc
$ 0,55
(46,67%)
8,65M
WGFWescan Goldfields Inc
$ 0,04
(100,00%)
5,97M
GPUSAlset AI Ventures Inc
$ 0,165
(-2,94%)
5,58M
MATEBlockmate Ventures Inc
$ 0,295
(3,51%)
3,48M
DMDataMetrex AI Limited
$ 0,005
(0,00%)
2,66M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
RVV
Revive Therapeutics
BOV
RCSL4R
RECRUSUL PN
TSXV
RECO
Reconnaissance Energy Af...
BOV
CVCB3
CVC BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten